CHYM vs DOCU
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CHYM · Chime Financial$31.33 ▲ 3.81%
DOCU · DocuSign$77.61 ▼ 1.66%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CHYM +47.4%
- DOCU +11.4%
Head to head
| Metric | CHYM | DOCU |
|---|---|---|
| Price | $31.33 | $77.61 |
| Change today | ▲ 3.81% | ▼ 1.66% |
| Market cap | $12.02B | $14.51B |
| Return, 3 months | +1.6% | +30.1% |
| Return, year to date | +24.5% | +13.5% |
| Return, 1 year | +54.0% | +11.3% |
| P/E (TTM) | 149.9 | 47.3 |
| P/B | 7.8 | 8.4 |
| P/E percentile vs own 5y | 14th | 77th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +26.8% | +9.4% |
| Net profit growth (YoY) | +103.0% | +23.4% |
| Gross margin | 88.7% | 79.5% |
| Operating margin | -2.1% | 12.0% |
| Net margin | -0.7% | 9.8% |
| Return on equity | -1.3% | 17.8% |
| Analyst target vs. price | +24.6% | -6.8% |
| Analyst buy share | 91% | 18% |
| RSI (14) | 62 | 51 |
| 30-day volatility | 37.1% | 36.3% |
| Max drawdown, 1 year | -41.1% | -42.9% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- DOCU is the largest of the group by market value.
- CHYM has returned the most over the past year.
- DOCU carries the lowest trailing P/E.
- CHYM is growing revenue fastest.
- DOCU keeps the most profit per dollar of sales.
- DOCU has been the calmest stock over the last 30 days.